<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Market Outlook on FinanClub</title>
    <link>https://finan.club/tags/market-outlook/</link>
    <description>Recent content in Market Outlook on FinanClub</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Thu, 04 Apr 2024 09:04:04 +0000</lastBuildDate><atom:link href="https://finan.club/tags/market-outlook/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>MMM</title>
      <link>https://finan.club/us/mmm/</link>
      <pubDate>Thu, 04 Apr 2024 09:04:04 +0000</pubDate>
      
      <guid>https://finan.club/us/mmm/</guid>
      <description>score:77
Chances: 3M&amp;rsquo;s prospects are improving, with the recent completion of the spin-off of its healthcare business, allowing the company to focus more on its core businesses. Investors applauded the spin-off of the healthcare business, indicating positive sentiment towards 3M&amp;rsquo;s strategic direction. The company&amp;rsquo;s settlement agreement with U.</description>
    </item>
    
    <item>
      <title>CRWD</title>
      <link>https://finan.club/us/crwd/</link>
      <pubDate>Wed, 10 Jan 2024 09:08:52 +0000</pubDate>
      
      <guid>https://finan.club/us/crwd/</guid>
      <description>score:172
Chances: CrowdStrike (CRWD) has received quite a bit of attention from Zacks.com users lately. Shares of cybersecurity company CrowdStrike (NASDAQ:CRWD) jumped 5.4% in the afternoon session after Morgan Stanley analyst Hamza Fodderwala upgraded the stock&amp;rsquo;s rating from Equal-Weight (Hold) to Overweight (Buy) and raised the price target from $203 to $304.</description>
    </item>
    
  </channel>
</rss>
